Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
April 20, 2017
The Fortune article “Digital Health Care Revolution” highlights the transformative impact of digital health care, with a focus on FDNA. FDNA’s innovative AI-powered diagnostic technologies, particularly their facial recognition software Face2Gene, are revolutionizing medical diagnostics by analyzing patient photos to identify rare genetic disorders. This advancement enables faster, more accurate diagnoses and personalized treatment plans, especially in areas lacking specialized genetic services. As digital health care advances, FDNA stands out for its contributions to improving patient outcomes and streamlining medical processes. The article emphasizes how digital decision support tools like FDNA are integral to the evolving landscape of health care.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…